Belury M A, Moya-Camarena S Y, Sun H, Snyder E, Davis J W, Cunningham M L, Vanden Heuvel J P
Department of Foods and Nutrition, Purdue University, West Lafayette, Indiana 47907, USA.
Toxicol Appl Pharmacol. 1998 Aug;151(2):254-61. doi: 10.1006/taap.1998.8443.
The regulation of gene expression via the peroxisome proliferator-activated receptor (PPAR) is believed to be critical in the effects of peroxisome proliferators on lipid metabolism and possibly in hepatocarcinogenesis. The involvement of PPAR in the peroxisome proliferator-mediated induction of fatty acid metabolizing genes such as acyl-CoA oxidase (ACO), fatty acid-binding protein (FABP), and cytochrome P450IVA1 (CYP4A1) has been clearly demonstrated. However, the induction by peroxisome proliferators of important growth regulatory genes such as c-myc has not been investigated extensively. In these studies we examined the dose-response relationships for the induction of mRNA for the PPAR-regulated and lipid metabolizing genes ACO, FABP, and CYP4A1 and compared them to the immediate early gene c-myc. Liver mRNA from rats fed various amounts of the peroxisome proliferator Wy14,643 for 13 weeks was utilized. The lipid metabolism and growth regulatory genes were induced by subchronic administration of Wy14,643 but to varying degrees and with different sensitivities. The lowest dose that resulted in a significant change in ACO and FABP expression was 10 ppm. The mRNA for CYP4A1 and c-myc was significantly affected at the lowest dose examined (5 ppm). Also, the maximal induction ranged from 10(5)-fold (CYP4A1) to less than 10-fold (FABP) relative to vehicle-treated animals. The accumulation of mRNA for ACO, FABP, and CYP4A1, but not c-myc, showed typical receptor-mediated dose-response relationships. The effects on gene expression were compared to rates of hepatic cell proliferation, a pertinent marker of tumor promotion and hepatocarcinogenesis. Surprisingly, ACO mRNA showed an excellent correlation (r2 = 0.9) while c-myc mRNA exhibited a poor correlation (r2 = 0.3) with cell proliferation in rat liver. Although the differences between the dose-response relationships of ACO and c-myc mRNA accumulation may suggest immediate early genes are not controlled by PPAR, evidence from PPARalpha null mice support this receptor in both lipid metabolism and growth regulatory genes. This study shows the complexity of responses mediated by peroxisome proliferators, with ACO being a good marker of PPAR-mediated events as well as cell proliferation, while c-myc, a known growth regulatory gene, was induced by Wy14,643 partially via PPAR but did not correlate well with cell proliferation.
通过过氧化物酶体增殖物激活受体(PPAR)对基因表达进行调控,被认为在过氧化物酶体增殖物对脂质代谢的影响以及可能在肝癌发生过程中起着关键作用。PPAR参与过氧化物酶体增殖物介导的脂肪酸代谢基因如酰基辅酶A氧化酶(ACO)、脂肪酸结合蛋白(FABP)和细胞色素P450IVA1(CYP4A1)的诱导已得到明确证实。然而,过氧化物酶体增殖物对重要生长调节基因如c-myc的诱导尚未得到广泛研究。在这些研究中,我们检测了PPAR调节的脂质代谢基因ACO、FABP和CYP4A1的mRNA诱导的剂量反应关系,并将它们与即时早期基因c-myc进行比较。使用了喂食不同剂量过氧化物酶体增殖物Wy14,643 13周的大鼠肝脏mRNA。脂质代谢和生长调节基因通过亚慢性给予Wy14,643而被诱导,但程度不同且敏感性各异。导致ACO和FABP表达发生显著变化的最低剂量为10 ppm。在检测的最低剂量(5 ppm)下,CYP4A1和c-myc的mRNA受到显著影响。此外,相对于溶剂处理的动物,最大诱导倍数范围从10^5倍(CYP4A1)到小于10倍(FABP)。ACO、FABP和CYP4A1的mRNA积累,但不是c-myc的mRNA积累,显示出典型的受体介导的剂量反应关系。将对基因表达的影响与肝细胞增殖率进行比较,肝细胞增殖率是肿瘤促进和肝癌发生的一个相关标志物。令人惊讶的是,ACO mRNA与大鼠肝脏中的细胞增殖显示出极好的相关性(r2 = 0.9),而c-myc mRNA与细胞增殖的相关性较差(r2 = 0.3)。尽管ACO和c-myc mRNA积累的剂量反应关系之间的差异可能表明即时早期基因不受PPAR控制,但来自PPARα基因敲除小鼠的证据支持该受体在脂质代谢和生长调节基因中的作用。这项研究表明了过氧化物酶体增殖物介导的反应的复杂性,ACO是PPAR介导事件以及细胞增殖的良好标志物,而c-myc作为一个已知的生长调节基因,部分通过PPAR被Wy14,643诱导,但与细胞增殖的相关性不佳。